 |
인쇄하기
취소
|
Korean drug makers still stuck in quagmire
Korean pharmaceutical companies are feeling pains from all sides. Relying too much on selling cheap generic drugs instead of developing original drugs, they lack competitiveness to take on global players.
On its part, the government forced the languishing domestic drug makers to substantially cut prices earlier last year, further chipping away at their bottom lines.
Recently, the Korea ...
On its part, the government forced the languishing domestic drug makers to substantially cut prices earlier last year, further chipping away at their bottom lines.
Recently, the Korea ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.